Advertisement

Topics

Cancer Genetics Announces Pricing of $3.5 Million Public Offering of Common Stock

12:32 EST 29 Jan 2019 | Investing News Network

Cancer Genetics (Nasdaq:CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today announced the pricing of a public offering of 15,217,392 shares of its common stock, offered at a price to the public of $0.23 per share, for gross proceeds of approximately $3.5 million, before deducting placement … Continued

The post Cancer Genetics Announces Pricing of $3.5 Million Public Offering of Common Stock appeared first on Investing News Network.

Original Article: Cancer Genetics Announces Pricing of $3.5 Million Public Offering of Common Stock

NEXT ARTICLE

More From BioPortfolio on "Cancer Genetics Announces Pricing of $3.5 Million Public Offering of Common Stock"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...